Acta Crystallographica Section E: Structure Reports Online - Volume 64, issue Pt 3

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cras neque tellus, ornare vel pulvinar luctus, vestibulum malesuada ante. Nullam pellentesque, ipsum vel fermentum tincidunt, velit neque molestie lacus, at iaculis purus mauris in nisl. Nullam vehicula imperdiet auctor. Mauris tempus, leo eget euismod condimentum, erat justo vehicula augue, vitae ornare elit felis nec libero. Etiam et quam sit amet metus dignissim dictum sed vitae purus. Phasellus gravida hendrerit risus vitae euismod. In elementum massa facilisis nulla pulvinar at pharetra leo pellentesque.

Electronic ISSN
1600-5368

Abstract

The title disubstituted naphthalene-1,4-dione, C24H16Cl2O2, has the two chloro­benzyl substituents related by a non-crystallographic twofold rotation axis, generating a chiral conformation; both enantiomers are present. The two chlorobenzene rings are n

Abstract

The title compound, C19H21NOS, is an inter­mediate for the synthesis of duloxetine hydro­chloride. In the mol­ecular structure, the thio­phene and naphthalene ring systems make a dihedral angle of 87.5°. All bond lengths and angles involving heteroatoms are as expected. In t

Abstract

In the title compound, C11H13NO3, the pyrrolidin-2-one ring is in an envelope conformation with the hydroxyl and 4-methoxy­phenyl substituents mutually cis. The methoxy group is slighty twisted away from the mean plane of the attached benzene ring. The mol­

Abstract

The title compound, C25H16O, was prepared by the condens­ation reaction of pyrene-1-carbaldehyde and acetophenone in ethanol solution at room temperature. The phenyl ring forms a dihedral angle of 39.10 (11)° with the pyrene ring system. In the crystal structure, adjacent py

Abstract

The title compound, [Zr(CH3)(C15H39N4Si3)], is a unique example of a triamido­amine-supported zirconium–methyl complex that crystallized as a monomer with trigonal–bipyramidal geometry at zirconium, featuring a Zr—C bond of 2.2963 (16) Å.

Abstract

The title compound, C25H26N2Te, was synthesized from bis­[1,3-bis­(3-phenyl­prop­yl)benzimidazolidin-2-yl­idene] and Te in a toluene solution. The molecule possesses a twofold rotation axis passing through the Te atom and the center of the benzimidazole ring syste